OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monitoring of autoantibodies against CYP4Z1 in patients with colon, ovarian, or prostate cancer
Christopher Khayeka–Wandabwa, Xiaoshuang Ma, Yingjie Jia, et al.
Immunobiology (2022) Vol. 227, Iss. 2, pp. 152174-152174
Closed Access | Times Cited: 6

Showing 6 citing articles:

Prostate cancer: Novel genetic and immunologic biomarkers
Mohammad Samare‐Najaf, Hosein Kouchaki, Seyed Moein Mahini, et al.
Clinica Chimica Acta (2024) Vol. 555, pp. 117824-117824
Closed Access | Times Cited: 3

Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Omar H. Abu-azzam, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2898-2898
Open Access | Times Cited: 6

There and Back Again: A Perspective on 20 Years of CYP4Z1
John P. Kowalski, Allan E. Rettie
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 6, pp. 498-507
Open Access | Times Cited: 1

Cytochrome 4Z1 Expression Connotes Unfavorable Prognosis in Ovarian Cancers
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Anas Satari, et al.
Medicina (2022) Vol. 58, Iss. 9, pp. 1263-1263
Open Access | Times Cited: 8

Targeting Cytochrome P450 Enzymes in Ovarian Cancers: new approaches for Tumour-Selective Interventions
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Omar H. Abu-azzam, et al.
(2023)
Open Access | Times Cited: 3

1‐Benzylimidazole attenuates the stemness of breast cancer cells through partially targeting CYP4Z1
Hai Qin, Yi Zhou, Liu Hai, et al.
Environmental Toxicology (2023) Vol. 39, Iss. 3, pp. 1505-1520
Closed Access

Page 1

Scroll to top